Počet záznamov: 1
rádioimunoterapia
SYS d016499 LBL 00000nx--j22000003--45-- 005 20240119201319.6 100 $a 19920502csloy0103----ba0 152 $b mesh 250 $a rádioimunoterapia $x AE $x CL $x EC $x ES $x HI $x IS $x MO $x MT $x NU $x PX $x SN $x ST $x TD $x VE $8 slo 300 1-
$a 92 $8 eng 300 1-
$a Antibodies, Monoclonal/therapeutic use (1984-1991) $8 eng 300 1-
$a Immunotherapy (1984-1991) $8 eng 300 1-
$a specific radioisotope/therapeutic use (1981-1991) $8 eng 330 1-
$a Radiotherapy where cytotoxic radionuclides are linked to antibodies in order to deliver toxins directly to tumor targets. Therapy with targeted radiation rather than antibody-targeted toxins (IMMUNOTOXINS) has the advantage that adjacent tumor cells, which lack the appropriate antigenic determinants, can be destroyed by radiation cross-fire. Radioimmunotherapy is sometimes called targeted radiotherapy, but this latter term can also refer to radionuclides linked to non-immune molecules (see RADIOTHERAPY). $8 eng 550 $3 sllk_un_auth*d018033 $Y Antibodies, Bispecific $5 B $a protilátky bišpecifické 686 $a E02.095.465.425.750 686 $a E02.186.750 686 $a E02.815.520 750 $a Radioimmunotherapy $8 eng 801 -0
$a US $b DNLM $c 19920502 801 -2
$a SK $b BA006 $c 20070706 820 $a coordinate with disease /radiother $8 eng 980 $x M
Počet záznamov: 1